WUXI BIOLOGICS (CAYMAN) INC revenue breakdown overview

WUXI BIOLOGICS (CAYMAN) INC revenue for the last year amounted to 40.75 B MXN, the most of which — 36.35 B MXN — came from its highest performing source at the moment, Biologics, the year earlier bringing 6.45 B MXN. The greatest contribution to the revenue figure was made by North America — last year it brought WUXI BIOLOGICS (CAYMAN) INC 19.40 B MXN, and the year before that — 24.67 B MXN.